You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. NOVEL ENZYME IMMOBILIZATION FOR BIOSENSOR APPLICATIONS (BACTERIA)

    SBC: Vertex Pharmaceuticals Inc.            Topic: N/A

    ENZYME CRYSTALS, CROSS-LINKED USING A BIFUNCTIONAL REAGENT SUCH AS GLUTARALDEHYDE, CONSTITUTE A NOVEL FORM OF ENZYME IMMOBILIZATION. SUCH CROSS-LINKED IMMOBILIZED ENZYME CRYSTALS (CLIECS) ARE SUPERIOR TO CONVEN- TIONALLY IMMOBILIZED ENZYMES IN MANY RESPECTS. FOR EXAMPLE, THE CRYSTAL LATTICE INTERACTIONS, SUPPLEMENTED BY CHEMICAL CROSS-LINKS, PROVIDE THE INDIVIDUAL ENZYME MOLECULES WITHIN A CLIEC W ...

    SBIR Phase I 1991 Department of Health and Human Services
  2. Fas Multimedia Library--Tools for Parents & Caregivers

    SBC: VIDA HEALTH COMMUNICATIONS, INC.            Topic: N/A

    We will produce a multi-media library of resources for parents, teachers and other caregivers of chwith fetal alcohol syndrome or fetal alcohol effects (FAS/FAE). Using prevalent and emerging media tspecifically to meet the needs of several target audiences, Vida will produce the first training, intool of its kind. Currently, due to an emphasis on prevention of FAS/FAE, media-based tools to enhane ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. INVESTIGATION OF SAFER TEST TUBES FOR LABORATORY USE

    SBC: Virafree Corp.            Topic: N/A

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  4. Water Soluble Polymer Microspheres As Vaccine Vehicles

    SBC: Virus Research Institute            Topic: N/A

    The majority of viral vaccines establish a state of systemic protective immunity by injection oflive attenuated or inactivated virus preparations. The use of injectable vaccines has reduced theincidence of many viral diseases. Nevertheless, their usage is associated with some undesirable sideeffects. Live attenuated virus vaccines can cause systemic complications; inactivated vaccines can haveloca ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. Microspheres--Water-Soluble Polymers as Vaccine Vehicles

    SBC: Virus Research Institute            Topic: N/A

    Modern molecular biology has provided us with a means of producing immunogens withunprecedented ease and precision, but these new methodologies generate purified immunogens that donot generally induce a strong immune response in the absence of an effective adjuvant. Thedevelopment of improved vaccine adjuvants for use in humans has therefore become a priority area ofresearch. Nevertheless, researc ...

    SBIR Phase I 1994 Department of Health and Human Services
  6. Live Oral Bacterial Vaccine Evaluation

    SBC: Virus Research Institute            Topic: N/A

    Vibrio cholera and Typhi salmonella are human pathogens that colonize gut and elicit bothmucosal and systemic protective immune responses. Novel HIV1 prophylactics will be developed usinggenetically attenuated strains of these organisms to derive single dose oral HIV1 vaccines. These neworal vaccines will be evaluated in the recently developed SHIV primate model. This study will provideessential d ...

    SBIR Phase I 1994 Department of Health and Human Services
  7. Live Vibrio Cholera as an Oral SIV Vaccine Vector

    SBC: Virus Research Institute            Topic: N/A

    Vibrio cholera is a human pathogen that colonizes the gut and elicits both mucosal and systemic proresponses. Novel SIV prophylactics will be developed using a genetically attenuated strain of this oSIV vaccines. These new oral vaccines will be evaluated in animals for their immunogenicity. As a coCollaborative Mucosal Immunology Group for AIDS vaccine (CMIG, AI35544), these vaccines will be evalp ...

    SBIR Phase I 1995 Department of Health and Human Services
  8. ORAL, LIVE, ATTENUATED VIBRIO VECTORED SSONNEI VACCINE

    SBC: Virus Research Institute            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  9. HIV-1 VACCINE FOR DEVELOPING COUNTRIES

    SBC: Virus Research Institute            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  10. ANTIHIV INTERBODIES FOR GENE THERAPY IN CD4+ CELLS

    SBC: Virus Research Institute            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government